Hormone Pellets vs Injections vs Creams: Delivery Methods Compared

The one idea to hold onto: the central trade-off is steady state versus peaks and troughs. Pellets give you the steadiest levels; injections give you a rise-and-fall pattern between doses; creams give you a daily on-off cycle. Counterintuitively, the steadiest option is not automatically the healthiest one — and understanding why is the heart of this page.

Why delivery method matters more than people think

Hormones are messengers that bind to specific receptors to produce their effect. The body did not evolve to receive those messengers as a flat, unchanging signal — it evolved around natural fluctuation. Testosterone, for example, peaks in the morning and runs lower at night, and is highest in the late summer and early fall. That rhythm is not incidental. As Dr. Greenleaf puts it, “it is the natural fluctuations in hormone levels that helps to keep receptors sensitive.”

This is the steady-state lesson, and it reframes the entire pellets-versus-injections debate. “Anything that stays in the body at steady state, the body is tuning it out.” When a hormone is held at a perfectly constant level, receptors can down-regulate — a desensitization Greenleaf compares to cortisol insensitivity. The clinical trap is predictable: the patient does great, then gradually does worse, and a provider who chases symptoms keeps escalating the dose. “In the long run, you’re going to be chasing the receptor insensitivity, and you’re going to end up giving more and more and more.”

So the way a hormone is delivered is not a packaging detail. A method that produces peaks and troughs mimics natural rhythm and tends to keep receptors responsive. A method that produces a perfectly flat steady state maximizes convenience and smoothness but, left unmanaged, can blunt receptor sensitivity over time. Every delivery method below sits somewhere on that spectrum, and choosing well means matching the method — and how you manage it — to the patient.

Pellets: steady release, hands-off, every few months

Subcutaneous hormone pellets are compounded crystalline implants placed under the skin, usually in the upper buttock or hip, where they dissolve slowly. They are reinserted roughly every three to six months, and between insertions the patient does nothing — no daily dose, no weekly injection. Pellets also offer high bioavailability: because the hormone enters the bloodstream directly, you do not have to worry about first-pass liver metabolism or gut absorption the way you do with oral forms.

The defining feature is a steady release that produces the smoothest blood levels of any common method. For patients who hate needles, forget daily applications, or simply want a set-and-forget approach, that is a powerful selling point — and it is why pellet practices are popular. The full insertion procedure, trocar technique, and aftercare are covered in our companion guide to the hormone pellet insertion procedure, and the science behind pellets in our hormone pellet therapy overview.

The honest downsides follow directly from the steadiness. First, pellets are the least reversible method: once placed, the hormone is committed for months and cannot simply be stopped. Greenleaf is blunt that estrogen pellets in particular carry a risk of inconsistent absorption, with cumulative rises that can occur for up to two years after a single placement. Second, absorption varies “from person to person, pharmacy to pharmacy, and batch to batch.” Third — and most important — pellets are the method most prone to the steady-state insensitivity described above. Greenleaf’s management is to space insertions out deliberately rather than reflexively redosing at three months: “Maybe try to go four months, see if you can go five months, so that you keep those receptors sensitive,” and to bridge symptomatic gaps with a short-acting form rather than placing the next pellet early.

Injections: peaks and troughs, frequent, self-administered

Injectable hormones — most commonly testosterone esters — are administered intramuscularly or subcutaneously on a schedule set by the ester’s duration. Cypionate and enanthate are typically given about every two weeks; short-acting propionate every two to three days; and long-acting depot formulations far less often. Patients can be taught to self-administer, which keeps injections inexpensive and accessible.

The signature of injections is a peak-and-trough curve: levels rise after each dose and fall before the next. Some patients feel that rise and fall, especially on longer intervals, and frequency is often adjusted to smooth it. But that same fluctuation is also injections’ quiet advantage — because levels are never perfectly flat, the method more closely mirrors the body’s natural rhythm and is less prone to the receptor desensitization that flat steady state can cause. Injections are also far more controllable and reversible than pellets: change the dose or interval at the next injection, or stop, and levels respond within days to weeks. This is exactly why Greenleaf reaches for a short-acting injection (or a topical) to bridge a patient between pellets and “keep those receptors sensitive to the hormone.” The trade-off is adherence and comfort: injections demand a needle on a recurring schedule, and not every patient will keep it up.

Creams and gels: daily, controllable, transference risk

Topical creams and gels are applied to the skin daily and absorbed transdermally. Their great strength is fine control: because they wash out of the system quickly, dosing is easy to titrate and easy to taper. Greenleaf describes topicals as “short-acting therapies that provide a quicker and more controllable ability to taper,” and uses them — like short-acting injections — to bridge gaps and adjust a patient who needs hands-on management. Transdermal dosing also bypasses the liver; her rule of thumb that “one hundred milligrams orally is equivalent to ten milligrams transdermally” reflects how much more efficiently a hormone reaches the blood when it skips first-pass metabolism.

The defining downside is transference. Until a topical fully absorbs, it can rub off through skin contact onto a partner, a child, or a pet — a real safety concern with testosterone in particular, and a counseling point every prescriber must cover. The second downside is adherence: a daily application only works if the patient actually applies it consistently, every day. Topicals are the most reversible and the most adjustable of the three methods, which makes them the natural tool for titration and bridging — but the least “set and forget.”

Pellets vs injections vs creams: side-by-side

No method wins every row. Read the table as a map of trade-offs, not a scoreboard — the right column depends entirely on the patient in front of you.

Factor	Pellets	Injections	Creams / Gels
Frequency	Every 3–6 months	Every 2–3 days to every 2 weeks	Daily
Blood-level stability	Most stable (steady state); absorption varies by batch	Peaks and troughs between doses	Daily on-off cycle; depends on adherence
Convenience	Highest — hands-off for months	Moderate — recurring self-injection	Lowest — daily application required
Procedure required	Yes — minor in-office insertion	Injection (often self-administered)	None
Transference risk	None	None	Yes — skin contact before absorption
Reversibility / titration	Lowest — committed for months once placed	Moderate — adjust at next dose	Highest — washes out quickly, easy to taper

A useful way to hold the table in your head: pellets optimize for stability and convenience, topicals optimize for control and reversibility, and injections sit in between — frequent but cheap, fluctuating but adjustable. This is why providers so often combine them, anchoring a patient on pellets and reaching for a topical or short-acting injection to fine-tune or bridge.

How providers choose

The choice is rarely about the molecule and almost always about the patient’s life and physiology. A few questions drive most decisions:

• How much does the patient value convenience versus control? A busy patient who wants to forget about it for months is a pellet candidate. A patient whose levels need careful titration — or who is early in optimization — is better served by an adjustable topical or injection.
• Is there a transference exposure at home? Young children or a partner trying to conceive can make a topical the wrong choice and push toward pellets or injections.
• Will the patient adhere? Daily creams and recurring injections only work if the patient keeps up. Pellets remove adherence from the equation — at the cost of reversibility.
• Is receptor insensitivity already in play? If a previously stable patient suddenly does worse, the answer is usually not more hormone. Greenleaf’s move is to space pellets out, sometimes have patients skip topical doses on weekends, and bridge with short-acting forms to re-sensitize receptors — “not just giving hormones based on symptoms.”
• How will you taper or exit? Stopping is straightforward with a topical, manageable with injections, and slow with pellets. Greenleaf will deliberately transition a patient toward short-acting therapy when a controllable taper is the goal.

Two clinical principles tie it together. First, check levels and keep them within normal limits — do not chase symptoms, because symptom-chasing is exactly how providers over-dose into insensitivity. Second, “patients don’t follow a textbook”: the safest practice often blends methods, using one for the baseline and another for adjustment. Getting that judgment right is what separates a confident hormone practice from a reactive one — and it is learned with reps, lab interpretation, and the dose-conversion math between forms, all of which Empire teaches.